Search results
Results from the WOW.Com Content Network
Buserelin, sold under the brand name Suprefact among others, is a medication which is used primarily in the treatment of prostate cancer and endometriosis. [3] [1] [2] It is also used for other indications such as the treatment of premenopausal breast cancer, uterine fibroids, and early puberty, in assisted reproduction for female infertility, and as a part of transgender hormone therapy.
A New Drug Application of bremelanotide for female sexual dysfunction was accepted by the US Food and Drug Administration (FDA) in June 2018, with a Prescription Drug User Fee Act (PDUFA) goal date set for 23 March 2019. [30] It was approved for use in the United States in June 2019. [3] [31] [32]
This is a complete list of estrogens and formulations that are approved by the FDA Tooltip Food and Drug Administration and available in the United States. Estrogens are used as hormonal contraceptives , in hormone replacement therapy , and in the treatment of gynecological disorders .
In 2004, 3M obtained FDA approval to market imiquimod as a treatment for superficial basal cell carcinoma. [ 21 ] In 2006, 3M sold its pharmaceutical business in the Americas to Graceway Pharmaceuticals , its European pharmaceutical business to Meda AB , and its pharmaceutical business in other territories to two private equity firms.
In September 2000 Danco Laboratories, a sub-licencee of the Population Council, received approval from the US Food and Drug Administration (FDA) to sell mifepristone under the brand name Mifeprex. In 2019, the first generic form of mifepristone in the United States became available, manufactured by GenBioPro .
Bazedoxifene, used as bazedoxifene acetate, is a medication for bone problems and possibly (pending more study) for cancer. [2] It is a third-generation selective estrogen receptor modulator (SERM). [3]
Developed by Gregory Pincus at G. D. Searle & Company, it was first approved on June 10, 1957, by the U.S. Food and Drug Administration for treatment of menstrual disorders. [1] The FDA approved an additional indication for use as a contraceptive on June 23, 1960, though it only became legally prescribable nationwide and regardless of the woman ...
Upjohn replied to that by lowering prices to half the price of the prescription drug [52] and by releasing a prescription 5% formula of Rogaine in 1997. [48] [59] In 1998, a 5% formulation of minoxidil was approved for nonprescription sale by the FDA. [60] The 5% aerosol foam formula was approved for medical use in the US in 2006.